Search

everythinglearnresearchcommunity

for

Search:↓

Low-level laser therapy is about 80% effective in treating hair loss, with best results in males, those who use it for over a year, and those with scalp conditions like dandruff and rash.

Oral medication is necessary to treat scalp fungus in children, with griseofulvin being the usual choice.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

New treatments for severe alopecia areata show promise but lack standard approval.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Exosomes from platelet-rich plasma may help heal wounds but need more research for hair growth and skin use.

Monitoring for adverse effects in clinical treatments is crucial.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Topical minoxidil is effective and safe for treating hair loss.

Low-level laser therapy is the most effective for hair loss, but other treatments also show promise.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Low-speed protocols with certified centrifuges and FDA-approved glass tubes are best for effective PRF outcomes.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.